VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 4.039
EU - Europa 2.533
AS - Asia 2.152
AF - Africa 355
SA - Sud America 347
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.439
Nazione #
US - Stati Uniti d'America 3.913
SG - Singapore 1.064
RU - Federazione Russa 749
IT - Italia 670
CN - Cina 557
IE - Irlanda 293
BR - Brasile 288
CI - Costa d'Avorio 210
VN - Vietnam 209
UA - Ucraina 166
DE - Germania 139
BE - Belgio 107
NL - Olanda 96
FR - Francia 93
CA - Canada 87
GB - Regno Unito 83
KR - Corea 77
IN - India 67
SN - Senegal 58
SE - Svezia 43
NG - Nigeria 40
MX - Messico 25
AR - Argentina 23
BD - Bangladesh 23
IQ - Iraq 21
TR - Turchia 21
JP - Giappone 20
PL - Polonia 17
HK - Hong Kong 15
EC - Ecuador 13
ES - Italia 13
CH - Svizzera 12
FI - Finlandia 12
IR - Iran 11
UZ - Uzbekistan 11
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
MA - Marocco 9
AU - Australia 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 7
VE - Venezuela 7
CL - Cile 6
ID - Indonesia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
BJ - Benin 5
GR - Grecia 5
KZ - Kazakistan 4
RO - Romania 4
AT - Austria 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
JM - Giamaica 3
PH - Filippine 3
RS - Serbia 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
GE - Georgia 2
JO - Giordania 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
Totale 9.435
Città #
Singapore 662
Dallas 512
Santa Clara 488
Chandler 373
Moscow 355
Chicago 306
Dublin 292
Ashburn 248
San Jose 242
Abidjan 210
Jacksonville 160
Civitanova Marche 145
Catania 131
Boardman 123
Los Angeles 111
Hefei 104
Beijing 101
Lauterbourg 76
Seoul 76
Andover 75
Cambridge 75
Lawrence 75
Grafing 73
Nanjing 71
Rotterdam 64
Dakar 58
Ho Chi Minh City 57
Toronto 54
Wingene 50
Council Bluffs 49
Houston 46
New York 41
Quintano 41
Hanoi 40
Wilmington 40
Dong Ket 39
Des Moines 38
Buffalo 33
Brussels 31
San Mateo 30
São Paulo 30
Agrigento 29
The Dalles 26
Columbus 23
Nanchang 21
Paternò 21
Stockholm 21
Abuja 20
Hebei 19
Munich 19
Tokyo 19
London 18
Kochi 17
Lagos 17
Orem 17
Palermo 16
Chennai 15
Denver 15
Ottawa 15
Saint Petersburg 15
Bremen 14
Jiaxing 14
Warsaw 14
Amsterdam 13
Atlanta 13
Tianjin 13
Hong Kong 12
Poplar 12
Redondo Beach 12
Rio de Janeiro 12
Shenyang 12
Brooklyn 11
Changsha 11
Nijmegen 11
Seattle 11
Frankfurt am Main 10
Manchester 10
Boston 9
Izegem 9
Mumbai 9
Da Nang 8
Guangzhou 8
Milan 8
Montreal 8
Paris 8
Pune 8
San Francisco 8
Ardabil 7
Bari 7
Erbil 7
Gravina di Catania 7
Jinan 7
Johannesburg 7
New Delhi 7
Rome 7
Zhengzhou 7
Belo Horizonte 6
Biên Hòa 6
Brasília 6
Brno 6
Totale 6.563
Nome #
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 237
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 197
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 184
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 172
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 168
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 165
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 164
Comparative proteomic analysis of insulin receptor isoform A and B signaling 157
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 157
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 155
BRAF(V600E) mutation and the biology of papillary thyroid cancer 148
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 145
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 144
Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation 144
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 144
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 141
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 135
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 135
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 135
Abstract 4612: In breast cancer cells IGF-I induces upregulation of DDR1 by suppressing miR-199a-5p via the PI3K/Akt pathway 132
PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis 131
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 130
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 128
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 128
Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study” 126
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 125
Insulin resistance: Any role in the changing epidemiology of thyroid cancer? 125
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 125
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 121
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 120
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 118
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 115
Editorial: Early diagnoses and treatments of uncommon breast cancers 114
Insulin receptor isoforms in physiology and disease: An updated view 113
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 107
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 107
Editorial: Resistance to Endocrine Therapies in Cancer 105
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 103
The IGF system in thyroid cancer:new concepts 103
Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection 102
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 102
COVID-19 and Diabetes: The Importance of Controlling RAGE 101
p73 tumor-suppressor activity is impaired in human thyroid cancer 98
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 97
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 97
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 97
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 96
Metabolic alterations of thyroid cancer as potential therapeutic targets 96
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 95
Insulin receptor isoforms in cancer 95
p53 family proteins in thyroid cancer 94
The p53-homologue p63 may promote thyroid cancer progression 93
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 93
Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study 93
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 91
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 90
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 90
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 88
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 88
Metyrapone restores nocturnal cortisol profile and impaired post-dexamethasone suppression in mild autonomous cortisol secretion due to bilateral adrenal incidentaloma 87
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 87
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 87
The emerging role of insulin receptor isoforms in thyroid cancer: Clinical implications and new perspectives 85
Editorial: A year in review: discussions in cancer endocrinology 84
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 84
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 83
Type 3 deiodinase: Role in cancer growth, stemness, and metabolism 83
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 82
GENOME WIDE ANALYSIS IN PAPILLARY THYROID CARCINOMA 82
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 81
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells 80
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 79
Thyrospheres an in vitro model for human thyroid carcinogenesis 79
Role of BRAF(V600) mutation in the resistance to gefinitib of thyroid cancer cells. 79
Long-acting insulin analogs and cancer 79
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 78
The expression of PTEN tumor suppressor is down regulated by the dominant negative p73 isoform ΔNp73 in thyroid cancer cells 75
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 74
Insulin-like growth factor II stimulates cell growth through the insulin receptor in brest cancer: a newly identified autocrine/paracrine loop 70
Manuale di endocrinologia geriatrica 70
Short-term adverse affects of anticancer drugs in type 2 diabetes patients. 68
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 68
REACTIVATION OF P53 MUTANTS BY SMALL COMPOUNDS MAY REPRESENT AN ADJUVANT THERAPY OF POORLY DIFFERENTIATED THYROID CANCER 67
EGFR INHIBITION ENHANCES THE SENSITIVITY OF POORLY DIFFERENTIATED THYROID CANCER CELLS TO CHEMOTHERAPY 67
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 63
Identification of Thyroid Cancer Stem Cells 62
REGULATION OF mirRNAS BY p53 FAMILIY MEMBERS IN THYROID CANCER CELLS 61
P63 EXPRESSION AND FUNCTION IN THYROID CANCER 60
Levels of histone acetylation in thyroid tumors 60
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 55
Totale 9.618
Categoria #
all - tutte 29.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 57 40
2021/2022555 49 91 15 7 82 3 82 29 42 0 17 138
2022/20231.252 82 43 36 155 124 182 34 230 269 24 40 33
2023/2024639 22 124 24 53 19 134 7 67 13 26 87 63
2024/20252.285 109 434 103 216 419 233 73 74 171 143 177 133
2025/20263.902 240 217 635 308 693 869 426 78 223 209 4 0
Totale 9.618